Rallybio Corp
RLYB · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Soteropoulos Paula: Form 4
Insider disclosure · Filed · Report period 16 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001739410 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- RLYB on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 234 Church Street, Suite 1020, New Haven, CT, 06510
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- Rallybio Holdings, LLC (to 07 Jun 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields